157 related articles for article (PubMed ID: 38461339)
21. The pharmacology of cannabinoid receptors and their ligands: an overview.
Pertwee RG
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
[TBL] [Abstract][Full Text] [Related]
22. The synthetic CB
Coronado-Álvarez A; Romero-Cordero K; Macías-Triana L; Tatum-Kuri A; Vera-Barrón A; Budde H; Machado S; Yamamoto T; Imperatori C; Murillo-Rodríguez E
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110301. PubMed ID: 33741446
[TBL] [Abstract][Full Text] [Related]
23. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
[TBL] [Abstract][Full Text] [Related]
25. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
[TBL] [Abstract][Full Text] [Related]
26. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
Tambaro S; Casu MA; Mastinu A; Lazzari P
Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
[TBL] [Abstract][Full Text] [Related]
28. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.
Ibrahim MM; Deng H; Zvonok A; Cockayne DA; Kwan J; Mata HP; Vanderah TW; Lai J; Porreca F; Makriyannis A; Malan TP
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10529-33. PubMed ID: 12917492
[TBL] [Abstract][Full Text] [Related]
29. The endocannabinoid system: Novel targets for treating cancer induced bone pain.
Sun J; Zhou YQ; Chen SP; Wang XM; Xu BY; Li DY; Tian YK; Ye DW
Biomed Pharmacother; 2019 Dec; 120():109504. PubMed ID: 31627091
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study.
Bar-Sela G; Zalman D; Semenysty V; Ballan E
Integr Cancer Ther; 2019; 18():1534735419881498. PubMed ID: 31595793
[No Abstract] [Full Text] [Related]
31. Nerves in Bone: Evolving Concepts in Pain and Anabolism.
Brazill JM; Beeve AT; Craft CS; Ivanusic JJ; Scheller EL
J Bone Miner Res; 2019 Aug; 34(8):1393-1406. PubMed ID: 31247122
[TBL] [Abstract][Full Text] [Related]
32. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.
Marino S; de Ridder D; Bishop RT; Renema N; Ponzetti M; Sophocleous A; Capulli M; Aljeffery A; Carrasco G; Gens MD; Khogeer A; Ralston SH; Gertsch J; Lamoureux F; Heymann D; Rucci N; Idris AI
EBioMedicine; 2019 Jun; 44():452-466. PubMed ID: 31151929
[TBL] [Abstract][Full Text] [Related]
33. The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma.
Rossi F; Tortora C; Punzo F; Bellini G; Argenziano M; Di Paola A; Torella M; Perrotta S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003519
[TBL] [Abstract][Full Text] [Related]
34. Cancer Pain Assessment and Classification.
Caraceni A; Shkodra M
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974857
[TBL] [Abstract][Full Text] [Related]
35. Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota's Medical Cannabis Program.
Anderson SP; Zylla DM; McGriff DM; Arneson TJ
J Oncol Pract; 2019 Apr; 15(4):e338-e345. PubMed ID: 30860938
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma.
de Almeida AS; Rigo FK; De Prá SD; Milioli AM; Dalenogare DP; Pereira GC; Ritter CDS; Peres DS; Antoniazzi CTD; Stein C; Moresco RN; Oliveira SM; Trevisan G
Cell Mol Neurobiol; 2019 Jul; 39(5):605-617. PubMed ID: 30850915
[TBL] [Abstract][Full Text] [Related]
37. A systematic review examining clinical markers and biomarkers of analgesic response to radiotherapy for cancer-induced bone pain.
Gardner K; Laird BJA; Fallon MT; Sande TA
Crit Rev Oncol Hematol; 2019 Jan; 133():33-44. PubMed ID: 30661656
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
